Trials / Completed
CompletedNCT06965816
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Centre Hospitalier de Saint-Denis · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study aims to better understand Alzheimer's disease by looking at brain scans, specifically MRI images, to detect early signs of brain changes linked to the disease. Researchers are focusing on the hippocampus, a part of the brain that shrinks in people with Alzheimer's. The study will also explore other brain changes that often happen alongside hippocampal shrinkage. By analyzing these brain images, the study hopes to find ways to diagnose Alzheimer's earlier and more accurately using advanced imaging techniques.
Conditions
- Alzheimer's Disease
- Hippocampus
- Brain Atrophy
- Magnetic Resonance Imaging
- Leukoaraiosis
- Neurodegenerative Diseases
- Cortical and Subcortical Atrophy
Timeline
- Start date
- 2022-11-24
- Primary completion
- 2023-05-24
- Completion
- 2023-05-24
- First posted
- 2025-05-11
- Last updated
- 2025-05-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06965816. Inclusion in this directory is not an endorsement.